SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
Regulatory science and biotech building at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
18 organizations at SITC 2026 present work in regulatory, policy & biotech building, led by pharma and biotech companies. Between them they bring 28 presentations to the program. Most represented: U.S. Food and Drug Administration, Merck & Co. and Bristol Myers Squibb. As of Nov 2, 2026.
Format
Top represented
Showing 1–7 of 18 organizations
| Organization | SITC 2026 Attendance |
|---|---|
U.S. Food and Drug Administration Silver Spring, MD | |
U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies. | Session Wed Nov 4 2:10pm–2:55pm Session Wed Nov 4 3:10pm–3:55pm Session Wed Nov 4 4:10pm–4:55pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Merck & Co. Rahway, NJ | |
Global pharmaceutical company, known as MSD outside the US and Canada, running a broad oncology research and clinical development program. | Booth Exhibiting at Booth 1228 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 3:10pm–3:55pm Session Thu Nov 5 12:00pm–1:30pm Talk Thu Nov 5 5:40pm–6:00pm Session Thu Nov 5 6:45pm–7:20pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Session Fri Nov 6 3:55pm–5:30pm Biotech Session: The Next Generation of Off-the-Shelf IO
Poster Sat Nov 7 12–1:30pm 6:40–8:10pm Poster Sat Nov 7 12–1:30pm 6:40–8:10pm |
Bristol Myers Squibb Princeton, NJ | |
Global pharmaceutical company whose immuno-oncology medicines include the checkpoint inhibitors nivolumab and ipilimumab. | Talk Thu Nov 5 1:45pm–1:55pm Talk Thu Nov 5 6:20pm–6:40pm Session Thu Nov 5 6:45pm–7:20pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Augusta University Augusta, GA | |
A public research university and academic health center in Georgia. | Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12–1:30pm 6:40–8:10pm Poster Sat Nov 7 12–1:30pm 6:40–8:10pm |
Iovance Biotherapeutics San Carlos, CA | |
Develops and commercializes tumor-infiltrating lymphocyte (TIL) cell therapies for people with solid tumors. | Booth Exhibiting at Booth 700 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 4:10pm–4:55pm Workshop Fri Nov 6 1:10pm–1:25pm Poster Sat Nov 7 12–1:30pm 6:40–8:10pm Poster Sat Nov 7 12–1:30pm 6:40–8:10pm Workshop Sat Nov 7 6:55pm–7:10pm |
Amgen Thousand Oaks, CA | |
Large biotechnology company whose oncology medicines include the bispecific T-cell engagers blinatumomab and tarlatamab. | Session Thu Nov 5 12:00pm–1:30pm Session Thu Nov 5 7:25pm–8:10pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Marengo Therapeutics Cambridge, MA | |
Clinical-stage biotech developing antibodies that target TCR V-beta chains to selectively activate T cell subsets against cancer. | Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable
Workshop Wed Nov 4 2:10pm–2:55pm Workshop Wed Nov 4 4:10pm–4:55pm Session Thu Nov 5 12:00pm–1:30pm Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships
|
Find buyers in regulatory, policy & biotech building
Tell us what you sell and we’ll find the people at organizations working on regulatory, policy & biotech building most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SITC 2026 by
Organization type
Research topic
- Cell Therapy 186
- Cancer Vaccines & Neoantigens 59
- Checkpoints, Bispecifics & New Agents 247
- Tumor Immunology & the Microenvironment 207
- Clinical Trials & Patient Care 220
- Biomarkers & Response Monitoring 137
- Spatial Biology, Models & Technology 160
- AI, Bioinformatics & Data 57
- Regulatory, Policy & Biotech Building 18
Exhibit hall
Everyone
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction